Courts are actively considering whether to end telemedicine prescribing of mifepristone, one of two drugs used in medication abortion, NPR Politics reported May 7. A ruling restricting that access would effectively eliminate medication abortion for millions of patients in states where clinic access is already limited — without any new legislation required.

The strategic shape here is straightforward: restricting telemedicine mifepristone accomplishes through judicial procedure what failed legislatively. Whoever wins this ruling controls access for a large share of the country. That's not an incidental outcome — it's the play.

Watch which Republican Senate incumbents in competitive states get asked to take a position. This is exactly the kind of ruling that forces a vote-adjacent choice — back the court or distance from it — ahead of the 2026 cycle.